Intricon Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021

Intricon Corporation is a joint development manufacturer (JDM) of micro medical components, sub-assemblies and final devices. The Company serves as a JDM partner to medical device original equipment manufacturers (OEMs) by designing, developing, engineering, manufacturing, packaging and distributing micro medical devices components and subassemblies for medical markets, such as diabetes, peripheral vascular, interventional pulmonology, electrophysiology and hearing healthcare. It manufactures microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components and complete catheter-based and body-worn devices for medical device manufacturers. The Company serves its market by offering medical device manufacturers, which have the capabilities to design, develop, manufacture, package and distribute medical devices. It operates globally with facilities in Minnesota, Illinois, California, Singapore, Indonesia and Germany.